Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 3/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.33 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
| ▸ | MMP13 | P45452 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20416908 | 0.95 | PLA2G2A (0.37) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL21169833 | 0.94 | PLA2G2A (0.36) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL23919645 | 0.94 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL21923886 | 0.94 | PLA2G2A (0.33) | PLA2G2APLA2G4APLA2G10 | |
| SCHEMBL21127448 | 0.93 | PLA2G2A (0.37) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL23849346 | 0.93 | PLA2G2A (0.37) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL23060310 | 0.93 | PLA2G2A (0.37) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL23109594 | 0.92 | PLA2G2A (0.35) | PLA2G2APLA2G4APLA2G10PTPN1PTPN2 | |
| SCHEMBL24208533 | 0.90 | MMP12 (0.35) | PLA2G2APLA2G4APLA2G10MMP12MMP13 | |
| SCHEMBL24119038 | 0.88 | MMP12 (0.35) | MMP12MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11139437-B2 | Compound and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20190214579-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11139437-B2 | Compound and organic electroluminescence device | RIF1, OR10J3, LEF1 | PLA2G2A 4600/4885PLA2G4A 4851/4885PLA2G10 4595/4885 |
| US-20190214579-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, RIF1, OR10J3 | PLA2G2A 4468/4885PLA2G4A 4828/4885PLA2G10 4488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.